Found: 57
Select item for more details and to access through your institution.
Low prevalence of Blastocystis sp. in active ulcerative colitis patients.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2015, v. 34, n. 5, p. 1039, doi. 10.1007/s10096-015-2312-2
- By:
- Publication type:
- Article
Is Ileoscopy With Biopsy Worthwhile in Patients Presenting With Symptoms of Inflammatory Bowel Disease?
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1998, v. 93, n. 2, p. 201, doi. 10.1111/j.1572-0241.1998.00201.x
- By:
- Publication type:
- Article
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1002629
- By:
- Publication type:
- Article
Safety and cost of infliximab for the treatment of belgian pediatric patients with Crohn's disease.
- Published in:
- Acta Gastro-Enterologica Belgica, 2012, v. 75, n. 4, p. 425
- By:
- Publication type:
- Article
A phase II randomized study of Combined Infusional Leucovorin Sodium and 5- FU versus the Leucovorin Calcium followed by 5-FU both in combination with Irinotecan or Oxaliplatin in patients with metastatic colorectal cancer.
- Published in:
- Acta Gastro-Enterologica Belgica, 2012, v. 75, n. 1, p. 14
- By:
- Publication type:
- Article
KRAS Status and Efficacy in the First-Line Treatment of Patients With Metastatic Colorectal Cancer Treated With FOLFIRI With or Without Cetuximab: The CRYSTAL Experience.
- Published in:
- 2008
- By:
- Publication type:
- Abstract
A202 TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 5.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 396, doi. 10.1093/jcag/gwz006.201
- By:
- Publication type:
- Article
A68 COST EFFECTIVENESS OF TIGHT CONTROL FOR CROHN'S DISEASE WITH ADALIMUMAB-BASED TREATMENT: ECONOMIC EVALUATION OF CALM TRIAL FROM CANADIAN PERSPECTIVE.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 136, doi. 10.1093/jcag/gwz006.067
- By:
- Publication type:
- Article
A nationwide database study on colectomy and colorectal cancer in ulcerative colitis: what is the role of appendectomy?
- Published in:
- Colorectal Disease, 2021, v. 23, n. 1, p. 64, doi. 10.1111/codi.15184
- By:
- Publication type:
- Article
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials.
- Published in:
- 2008
- By:
- Publication type:
- journal article
High-Dose Cyclosporine Had No Additional Clinical Benefit over Low-Dose Cyclosporine for Severe Ulcerative Colitis.
- Published in:
- Annals of Internal Medicine, 2004, v. 141, n. 5, p. 377
- By:
- Publication type:
- Article
The association between intensified medical treatment, time to surgery and ileocolic specimen length in Crohn's disease.
- Published in:
- Colorectal Disease, 2017, v. 19, n. 6, p. 551, doi. 10.1111/codi.13567
- By:
- Publication type:
- Article
Early reconstruction of the leaking ileal pouch-anal anastomosis: a novel solution to an old problem.
- Published in:
- Colorectal Disease, 2015, v. 17, n. 5, p. 426, doi. 10.1111/codi.12867
- By:
- Publication type:
- Article
Prolonged preoperative hospital stay is a risk factor for complications after emergency colectomy for severe colitis.
- Published in:
- Colorectal Disease, 2013, v. 15, n. 11, p. 1392, doi. 10.1111/codi.12328
- By:
- Publication type:
- Article
The effect of appendectomy on the course of ulcerative colitis: a systematic review.
- Published in:
- Colorectal Disease, 2012, v. 14, n. 5, p. 545, doi. 10.1111/j.1463-1318.2011.02600.x
- By:
- Publication type:
- Article
Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer.
- Published in:
- British Journal of Cancer, 2013, v. 108, n. 3, p. 493, doi. 10.1038/bjc.2012.545
- By:
- Publication type:
- Article
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 5, p. 1808, doi. 10.1007/s10620-023-08252-1
- By:
- Publication type:
- Article
Clinical Decision Support Tools: The Evolution of a Revolution.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 4, p. 405, doi. 10.1002/cpt.334
- By:
- Publication type:
- Article
Hyperbaric oxygen therapy for the treatment of perianal fistulas in Crohn's disease (HOT-TOPIC): study protocol of a prospective interventional cohort study with one-year follow-up.
- Published in:
- Undersea & Hyperbaric Medicine, 2019, v. 46, n. 1, p. 45, doi. 10.22462/01.03.2019.5
- By:
- Publication type:
- Article
Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2006, v. 24, n. 7, p. 1087, doi. 10.1111/j.1365-2036.2006.03082.x
- By:
- Publication type:
- Article
The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2004, v. 19, n. 7, p. 749, doi. 10.1111/j.1365-2036.2004.01904.x
- By:
- Publication type:
- Article
Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn’s disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2001, v. 15, n. 4, p. 463, doi. 10.1046/j.1365-2036.2001.00956.x
- By:
- Publication type:
- Article
Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 3, p. 333, doi. 10.1111/apt.14834
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 12, p. 1578, doi. 10.1111/apt.14672
- By:
- Publication type:
- Article
Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab—Authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Reliability of histologic assessment in patients with eosinophilic oesophagitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 7, p. 940, doi. 10.1111/apt.14559
- By:
- Publication type:
- Article
Physicians’ perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 6, p. 773, doi. 10.1111/apt.14514
- By:
- Publication type:
- Article
The development of a magnetic resonance imaging index for fistulising Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 5, p. 516, doi. 10.1111/apt.14190
- By:
- Publication type:
- Article
Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 3, p. 292, doi. 10.1111/apt.14164
- By:
- Publication type:
- Article
Editorial: anti-tumour necrosis factor α antibodies - can efficacy be regained? Authors' reply.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 8, p. 1128, doi. 10.1111/apt.13994
- By:
- Publication type:
- Article
Review article: dose optimisation of infliximab for acute severe ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 5, p. 617, doi. 10.1111/apt.13913
- By:
- Publication type:
- Article
Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2016, v. 44, n. 10, p. 1018, doi. 10.1111/apt.13803
- By:
- Publication type:
- Article
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 10, p. 1170, doi. 10.1111/apt.13398
- By:
- Publication type:
- Article
Review article: pharmacological aspects of anti- TNF biosimilars in inflammatory bowel diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 10, p. 1158, doi. 10.1111/apt.13402
- By:
- Publication type:
- Article
Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 10, p. 1200, doi. 10.1111/apt.13408
- By:
- Publication type:
- Article
Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 9, p. 1082, doi. 10.1111/apt.13387
- By:
- Publication type:
- Article
Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2015, v. 41, n. 5, p. 409, doi. 10.1111/apt.13076
- By:
- Publication type:
- Article
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2015, v. 41, n. 1, p. 77, doi. 10.1111/apt.13001
- By:
- Publication type:
- Article
Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 40, n. 5, p. 486, doi. 10.1111/apt.12863
- By:
- Publication type:
- Article
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 10, p. 1236, doi. 10.1111/apt.12499
- By:
- Publication type:
- Article
One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 2, p. 204, doi. 10.1111/apt.12145
- By:
- Publication type:
- Article
Review article: defining remission in ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 2, p. 113, doi. 10.1111/j.1365-2036.2011.04701.x
- By:
- Publication type:
- Article
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 12, p. 1296, doi. 10.1111/j.1365-2036.2010.04304.x
- By:
- Publication type:
- Article
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Intestinal Ultrasound Early on in Treatment Follow-up Predicts Endoscopic Response to Anti-TNFα Treatment in Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 10, p. 1598, doi. 10.1093/ecco-jcc/jjac072
- By:
- Publication type:
- Article
Systematic Review: Histological Scoring of Strictures in Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 6, p. 734, doi. 10.1093/ecco-jcc/jjz177
- By:
- Publication type:
- Article
Appendectomy for Therapy-Refractory Ulcerative Colitis Results in Pathological Improvement of Colonic Inflammation: Short-Term Results of the PASSION Study.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 2, p. 165, doi. 10.1093/ecco-jcc/jjy127
- By:
- Publication type:
- Article
Ultrasound for Assessing Disease Activity in IBD Patients: A Systematic Review of Activity Scores.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 8, p. 920, doi. 10.1093/ecco-jcc/jjy048
- By:
- Publication type:
- Article
Profoundly Expanded T-cell Clones in the Inflamed and Uninflamed Intestine of Patients With Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 7, p. 831, doi. 10.1093/ecco-jcc/jjx012
- By:
- Publication type:
- Article